Literature DB >> 29500512

Mesenchymal stem cells inhibit hypoxia-induced inflammatory and fibrotic pathways in bladder smooth muscle cells.

Bridget Wiafe1, Adetola Adesida2, Thomas Churchill2, Peter Metcalfe2,3.   

Abstract

PURPOSE: Partial bladder outlet obstruction is a multifactorial urological condition in which hypoxia plays a significant role. We recently investigated hypoxia's role as a single stressor and found that hypoxia induced an intense inflammatory and profibrotic switch in bladder smooth muscle cells (bSMCs). With the immunomodulatory capacity of mesenchymal stem cells (MSCs), we aimed to investigate if the hypoxia-signaling pathways can be mitigated using MSCs.
METHODS: Bladder smooth muscle cells were cultured in 3% oxygen tension for 72 h with either the direct or indirect co-culture with bone marrow derived MSCs. High pore density transwells were used for indirect co-cultures. Total RNA was extracted for gene expression analysis and the Mesoscale multiplex assay was used for secreted cytokines and growth factor measurements. Total collagen contents were determined using the Sirius Red collagen assay.
RESULTS: Hypoxia induced increase of HIF3α, VEGF, TGFβ1, TNFα, IL-1β, IL-6, αSMA, and total collagen expression and decreased IL-10 levels in bSMCs. Both direct and indirect MSCs co-cultures inhibited > 50% of hypoxia-induced TGFβ1 and IL-6 expression (p < 0.005) in a HIF-independent manner. Also, both MSCs co-culture techniques induced > 200% increase in IL-10 protein (p < 0.005) and inhibited hypoxia-induced αSMA, collagen I and III transcripts as well as total collagen proteins (p < 0.0001). Contrastingly, the hypoxia-induced IL-1β and TNFα were inhibited by only the direct co-cultures (p < 0.05).
CONCLUSIONS: MSCs co-culture with bSMCs potently mitigates hypoxia-induced inflammatory and profibrotic pathways. This work has elucidated the role of cell-cell contact and paracrine immunomodulatory mechanisms of MSCs action and opened avenues for therapeutic intervention.

Entities:  

Keywords:  Bladder smooth muscle cells; Hypoxia signaling pathway; Immunomodulatory property; Inflammatory cytokine; Mesenchymal stem cells; Paracrine action

Mesh:

Substances:

Year:  2018        PMID: 29500512     DOI: 10.1007/s00345-018-2247-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  29 in total

1.  Transforming growth factor-beta1-induced hypertrophy and matrix expression in human bladder smooth muscle cells.

Authors:  Pamela S Howard; Umberto Kucich; Douglas E Coplen; Yuling He
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Simulated bladder pressure stimulates human bladder smooth muscle cell proliferation via the PI3K/SGK1 signaling pathway.

Authors:  Lin Chen; Tang-Qiang Wei; Yan Wang; Jie Zhang; Hong Li; Kun-Jie Wang
Journal:  J Urol       Date:  2012-06-15       Impact factor: 7.450

3.  Benefits of mesenchymal stem cells after partial bladder outlet obstruction.

Authors:  Bader Al-Saikan; Jie Ding; Edward Tredget; Peter Metcalfe
Journal:  Can Urol Assoc J       Date:  2016-01-14       Impact factor: 1.862

4.  Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data.

Authors:  Lynn L Woo; Stacy T Tanaka; Govindaraj Anumanthan; John C Pope; John C Thomas; Mark C Adams; John W Brock; Neil A Bhowmick
Journal:  J Urol       Date:  2011-01-21       Impact factor: 7.450

5.  Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves.

Authors:  K MacRae Dell; B B Hoffman; M B Leonard; F N Ziyadeh; S L Schulman
Journal:  Urology       Date:  2000-08-01       Impact factor: 2.649

6.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

7.  Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts.

Authors:  J A Elias; V Lentz; P J Cummings
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

8.  Bladder stromal loss of transforming growth factor receptor II decreases fibrosis after bladder obstruction.

Authors:  Govindaraj Anumanthan; Stacy T Tanaka; Cyrus M Adams; John C Thomas; Marcia L Wills; Mark C Adams; Simon W Hayward; Robert J Matusik; Neil A Bhowmick; John W Brock; John C Pope
Journal:  J Urol       Date:  2009-08-18       Impact factor: 7.450

9.  Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up.

Authors:  Cristian Sager; Juan C Lopez; Victor Duran; Carol Burek; Ernesto Perazzo
Journal:  Int Braz J Urol       Date:  2009 May-Jun       Impact factor: 1.541

10.  Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation.

Authors:  Xiaoxiao Jiang; Yaping Chen; Haitao Zhu; Bo Wang; Ping Qu; Renfu Chen; Xiaoqing Sun
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

View more
  8 in total

1.  Mesenchymal stem cells ameliorate partial bladder outlet obstruction-induced epithelial-mesenchymal transition type II independent of mast cell recruitment and degranulation.

Authors:  Rutuja Kadam; Bridget Wiafe; Peter D Metcalfe
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

2.  Human amniotic fluid stem cells can alleviate detrusor dysfunction caused by bladder outlet obstruction in rats.

Authors:  Ching-Chung Liang; Wen-Chu Huang; Steven W Shaw; Yung-Hsin Huang; Tsong-Hai Lee
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

3.  Circular RNA Plasmacytoma Variant Translocation 1 (CircPVT1) knockdown ameliorates hypoxia-induced bladder fibrosis by regulating the miR-203/Suppressor of Cytokine Signaling 3 (SOCS3) signaling axis.

Authors:  Teng Li; Yi Xing; Guoxian Zhang; Yan Wang; Yinsheng Wei; Lingang Cui; Shaojin Zhang; Qingwei Wang
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 4.  New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome.

Authors:  Ahmed Abdal Dayem; Kwonwoo Song; Soobin Lee; Aram Kim; Ssang-Goo Cho
Journal:  BMB Rep       Date:  2022-05       Impact factor: 5.041

5.  Two New Potential Therapeutic Approaches in Radiation Cystitis Derived from Mesenchymal Stem Cells: Extracellular Vesicles and Conditioned Medium.

Authors:  Carole Helissey; Nathalie Guitard; Hélène Théry; Sylvie Goulinet; Philippe Mauduit; Maria Girleanu; Anne-Laure Favier; Michel Drouet; Charles Parnot; Cyrus Chargari; Sophie Cavallero; Sabine François
Journal:  Biology (Basel)       Date:  2022-06-28

6.  Human Urine-Derived Stem Cells Improve Partial Bladder Outlet Obstruction in Rats: Preliminary Data and microRNA-mRNA Expression Profile.

Authors:  Menjiang Tu; Rui Wang; Pei Zhu; Qingqing Wang; Bishao Sun; Keshi Lu; Jiawei Zhang; Weijie Xie; Huan Guo; Shulin Li; Yuqi Wu; Xiangwei Wang
Journal:  Stem Cell Rev Rep       Date:  2022-03-01       Impact factor: 6.692

7.  Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model.

Authors:  Yi Huang; Jie Gao; Yiduo Zhou; Shuo Wu; Yunpeng Shao; Haoliang Xue; Baixin Shen; Liucheng Ding; Zhongqing Wei
Journal:  Stem Cell Res Ther       Date:  2020-07-10       Impact factor: 6.832

Review 8.  Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome.

Authors:  Chao Wen; Liping Xie; Chenxia Hu
Journal:  J Cell Mol Med       Date:  2021-12-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.